This is a reminder for both Drug Manufactures and Sponsors that, beginning with the Q1 2014 quarterly invoices, negative amounts will be handled differently than in previous quarters.
This change is described in the HPMS memo dated January 22, 2014 entitled “Updates to the Process for Resolving Coverage Gap Discount Program Negative Invoiced Amounts” in the “Addressing Negative Amounts on Future invoices” section. This memo can be located on the TPA website under the “Invoice Reconciliation Information” section.
In short, negative amounts represent funds that Plan Sponsors owe to Drug Manufacturers as the result of adjusted or deleted PDEs during the quarter. Conversely, negative amounts represent funds that the Drug Manufactures expect to receive from Plan Sponsors.
Both Sponsors and Manufacturers must confirm negative amounts paid and amounts received, as would be the case with positive amounts.
Please refer to the aforementioned HPMS memo for complete details. If you have any additional questions or concerns, please contact TPA Operations either by Email at
tpaoperations@tpadministrator.com, or by telephone at 1-877-534-2772, Option 1.